Product Information
ESTARYLLA 0.25-0.035 MG TABLET is a generic product labeled by Xiromed LLC, priced at $0.1257 per EA under NDC 70700011985. Its NADAC has been published 411 times since Aug 15, 2018.
Manufacturer
Xiromed LLCNDC
70700011985
Classification
Generic
Dosage Form
KIT
Last Updated
6/17/2026
Approval Type
Generic (ANDA)
FDA Application
ANDA090794On Market Since
1/1/2018
Price Statistics
The NADAC for ESTARYLLA 0.25-0.035 MG TABLET has been published 411 times since Aug 15, 2018, and over the history we have for it it has declined 51.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1257 per EA |
|---|---|
| All-time high | $0.2653 (Nov 14, 2018) |
| All-time low | $0.1011 (Nov 20, 2024) |
| 52-week high | $0.1351 |
| 52-week low | $0.1230 |
| Median price | $0.1539 |
| Average price | $0.1764 |
| Largest weekly change | -21.9% (Nov 20, 2024) |
| Weeks tracked | 411 |
| Tracking since | Aug 15, 2018 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of ESTARYLLA 0.25-0.035 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ESTARYLLA 0.25-0.035 MG TABLET, manufactured by Xiromed LLC, is $0.1257 per EA (NDC 70700011985), effective Jun 24, 2026.
How has the price of ESTARYLLA 0.25-0.035 MG TABLET changed over time?
Over the history we have for it, the NADAC for ESTARYLLA 0.25-0.035 MG TABLET has declined 51.6%. It has been tracked across 411 weekly CMS publications since Aug 15, 2018.
What are the highest and lowest recorded NADAC prices for ESTARYLLA 0.25-0.035 MG TABLET?
Since Aug 15, 2018, the NADAC for ESTARYLLA 0.25-0.035 MG TABLET has ranged from a low of $0.1011 (Nov 20, 2024) to a high of $0.2653 (Nov 14, 2018), with a median of $0.1539 per EA.
Are there cheaper alternatives to ESTARYLLA 0.25-0.035 MG TABLET?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as ESTARYLLA 0.25-0.035 MG TABLET, but none are currently priced below it.
Who manufactures ESTARYLLA 0.25-0.035 MG TABLET?
ESTARYLLA 0.25-0.035 MG TABLET (NDC 70700011985) is labeled by Xiromed LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification